ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹0.01 Cr | ₹1.35 Cr | ₹1.66 Cr | ₹2.50 Cr | ₹2.53 Cr |
What is the latest Total Non-Current Liabilities ratio of ANUH PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹0.01 Cr |
| Mar2024 | ₹1.35 Cr |
| Mar2023 | ₹1.66 Cr |
| Mar2022 | ₹2.50 Cr |
| Mar2021 | ₹2.53 Cr |
How is Total Non-Current Liabilities of ANUH PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.01 Cr | -99.33 | |
| Mar2024 | ₹1.35 Cr | -18.67 | |
| Mar2023 | ₹1.66 Cr | -33.69 | |
| Mar2022 | ₹2.50 Cr | -1.23 | |
| Mar2021 | ₹2.53 Cr | - | |
Compare Total Non-Current Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹775.3 Cr | -5% | 2.3% | -26.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | -5% |
2.3% |
-26.6% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses